Condition

Acute Lymphoblastic Leukemia, Adult clinical trials and research

• 12Clinical trials
• 5Countries

Newest Acute Lymphoblastic Leukemia, Adult clinical trials

All recruiting trials (12)

• Pediatric-style chemotherapy with venetoclax and immunotherapy for adults with Ph-negative acute lymphoblastic leukemia

  This treatment plan tests whether pediatric-style chemotherapy combined with venetoclax and optional immunotherapy helps people aged 14–60 with newly diagnosed Ph-negative ALL achieve remission and clear minimal residual disease.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07495631

• Combined chemotherapy with venetoclax and stem cell transplant for adults with Ph-negative ALL

  This trial will try a treatment plan that gives intensive chemotherapy including venetoclax, followed by consolidation chemotherapy and possible allogeneic stem cell transplant, for adults aged 18–60 with Philadelphia chromosome–negative acute lymphoblastic leukemia.

  Recruiting Phase 2/3 Shanxi Bethune Hospital · Taiyuan, Shanxi · NCT07059156

• Comparing two conditioning regimens for stem cell transplantation in adult leukemia patients

  This study is testing which of two radiation treatments helps adults with leukemia do better after getting a stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Zhengzhou University · Zhengzhou, Henan · NCT06564545

• Comparing two conditioning regimens for stem cell transplantation in adult leukemia patients

  This study is testing which of two treatment methods, Total Body Irradiation or Total Marrow Irradiation, works better for adults with leukemia getting stem cell transplants to kill cancer cells while causing less harm to healthy tissue.

  Recruiting Phase 2 The First Affiliated Hospital of Zhengzhou University · Zhengzhou, Henan · NCT06557161

• Combining chemotherapy with CAR-T cell therapy for newly diagnosed adult patients with Philadelphia Chromosome Negative ALL

  This study is testing if combining CAR-T cell therapy with chemotherapy can help adults newly diagnosed with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia feel better and live longer.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT06481241

• Combining CAR-T therapy with chemotherapy for newly diagnosed Ph+ acute lymphoblastic leukemia

  This study is testing a new treatment that combines CAR-T therapy with chemotherapy to see if it can help adults with newly diagnosed Ph+ acute lymphoblastic leukemia feel better and live longer.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT06481228

• Evaluating TGRX-814 in patients with blood cancers

  This study is testing a new drug called TGRX-814 to see if it is safe and effective for people with blood cancers like lymphoma and leukemia.

  Recruiting Phase 1/2 Shenzhen TargetRx Co., Ltd. · Tianjin, Tianjin Municipality · NCT06206174

• Treatment for adult patients with specific types of lymphoma and leukemia

  This study is testing a new treatment plan using a combination of medications before a stem cell transplant to see if it helps adults with certain types of lymphoma and leukemia stay in remission.

  Recruiting Phase 1 Fifth Affiliated Hospital, Sun Yat-Sen University · Zhuhai, Guangdong · NCT06060782

• CAR T-cell therapy for patients with kidney issues

  This study is testing if CAR T-cell therapy can be safely given to patients with kidney problems who are getting chemotherapy for blood cancers like multiple myeloma, leukemia, or lymphoma.

  Recruiting Phase 2 Northside Hospital, Inc. · Atlanta, Georgia · NCT05909059

• Understanding why CAR T cells don't last in leukemia treatment

  This study looks at kids and young adults with leukemia to see why CAR T cells don't stick around long enough after treatment and what might help them last longer.

  Recruiting at 3 sites University College, London · London and 2 other locations · NCT05809284

• Evaluating pediatric-like treatment for young adults with Ph-negative acute lymphoblastic leukemia

  This study is testing a pediatric-style treatment for young adults with Ph-negative acute lymphoblastic leukemia in Argentina to see how well it works and what side effects it may have.

  Recruiting at 2 sites Grupo Argentino de Tratamiento de la Leucemia Aguda · Paraná, Entre Ríos Province and 1 other locations · NCT05127148

• Treatment for relapsed or refractory CD19+ lymphoid diseases using engineered T cells

  This study is testing a new treatment using specially modified immune cells to help adults and children with certain types of blood cancers that haven't responded to other therapies.

  Recruiting at 2 sites Phase 1/2 University Hospital Heidelberg · Heidelberg and 1 other locations · NCT03676504

Related topics

Quick answers

How many Acute Lymphoblastic Leukemia, Adult clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in China (8 trials), Argentina (1 trial), United States (1 trial), Germany (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 2, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →